Mear ynformaasje ― Frysk

Urticaria presintearret gewoanlik mei yntinsyf jeukende ferhege welts. It wurdt soms begelaat troch swelling fan 'e ûnderlizzende weefsels. Behanneling omfettet primêr it foarkommen fan triggers, as bekend. Earste-line medikaasje omfettet nijere antihistaminen, dy't as nedich kinne wurde oanpast oan hegere doses. Oare medisinen lykas âldere antihistaminen, H2-blokkers, leukotriene-receptor-antagonisten, sterkere antihistaminen, en koarte kursussen fan kortikosteroïden kinne wurde tafoege as ekstra stipe. Yn gefallen dêr't urticaria nettsjinsteande dizze maatregels oanhâldt, kinne pasjinten wurde ferwiisd nei spesjalisten foar ekstra terapyen lykas omalizumab of cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Dizze resinsje sketst de lêste rjochtlinen foar it behanneljen fan urticaria en biedt nije begripen fan de oarsaken.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids